Concepedia

Miloš Pešek

MP

Statistics

Publications

45

Citations

2.7K

H-Index

22

Active since

1998

Affiliations

Charles University(Current)

Masaryk University

Genomac

Thomayer University Hospital

University Hospital Brno

Miloš Pešek is an author at Charles University specializing in medicine, lung cancer, and pathology.

ORCID

Top concepts

Publications per year

1998–2022

45

Publications

45

Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial

U. Gatzemeier, Aleksandra Szczęsna, E. Kaukel et al. · Journal of Clinical Oncology · 2007 · 878 citations · Full text

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

John V. Heymach, Bruce E. Johnson, Diane Prager et al. · Journal of Clinical Oncology · 2007 · 292 citations

Gefitinib Versus Vinorelbine in Chemotherapy-Naïve Elderly Patients With Advanced Non–Small-Cell Lung Cancer (INVITE): A Randomized, Phase II Study

Lucio Crinò, Federico Cappuzzo, Petr Zatloukal et al. · Journal of Clinical Oncology · 2008 · 217 citations

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

Petr Zatloukal, Luboš Petruželka, Milada Zemanová et al. · Lung Cancer · 2003 · 161 citations

, , +7

A phase II trial of ZD6474 plus docetaxel in patients with previously treated NSCLC: Follow-up results

John V. Heymach, Bruce E. Johnson, Diane Prager et al. · Journal of Clinical Oncology · 2006 · 73 citations

, , +12

1–5 of 45